244 filings
Page 8 of 13
4
AMLX
Amylyx Pharmaceuticals Inc
4 Jan 23
Amylyx Pharmaceuticals / JAMES M FRATES ownership change
9:33pm
8-K
AMLX
Amylyx Pharmaceuticals Inc
6 Dec 22
Entry into a Material Definitive Agreement
4:06pm
10-Q
2022 Q3
AMLX
Amylyx Pharmaceuticals Inc
Quarterly report
10 Nov 22
4:12pm
8-K
AMLX
Amylyx Pharmaceuticals Inc
10 Nov 22
Amylyx Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:06pm
8-K
AMLX
Amylyx Pharmaceuticals Inc
2 Nov 22
Departure of Directors or Certain Officers
4:01pm
424B4
AMLX
Amylyx Pharmaceuticals Inc
7 Oct 22
Prospectus supplement with pricing info
4:30pm
EFFECT
AMLX
Amylyx Pharmaceuticals Inc
7 Oct 22
Notice of effectiveness
12:15am
S-1MEF
AMLX
Amylyx Pharmaceuticals Inc
6 Oct 22
Registration of additional securities for an S-1
9:20pm
S-1
AMLX
Amylyx Pharmaceuticals Inc
IPO registration
4 Oct 22
4:03pm
CORRESP
AMLX
Amylyx Pharmaceuticals Inc
4 Oct 22
Correspondence with SEC
12:00am
CORRESP
AMLX
Amylyx Pharmaceuticals Inc
4 Oct 22
Correspondence with SEC
12:00am
SC 13D/A
AMLX
Amylyx Pharmaceuticals Inc
30 Sep 22
Amylyx Pharmaceuticals / Morningside Venture Investments ownership change
4:05pm
8-K
AMLX
Amylyx Pharmaceuticals Inc
30 Sep 22
Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS
7:48am
SC 13G
AMLX
Amylyx Pharmaceuticals Inc
21 Sep 22
Amylyx Pharmaceuticals / MILLENNIUM MANAGEMENT ownership change
4:16pm
SC 13G/A
AMLX
Amylyx Pharmaceuticals Inc
9 Sep 22
Amylyx Pharmaceuticals / VIKING GLOBAL INVESTORS ownership change
9:50pm
4
Viking Global Opportunities Illiquid Investments Sub-Master LP
9 Sep 22
Amylyx Pharmaceuticals / OLE ANDREAS HALVORSEN ownership change
9:48pm
UPLOAD
AMLX
Amylyx Pharmaceuticals Inc
31 Aug 22
Letter from SEC
12:00am
DRS
AMLX
Amylyx Pharmaceuticals Inc
24 Aug 22
Draft registration statement
12:00am
8-K
AMLX
Amylyx Pharmaceuticals Inc
11 Aug 22
Amylyx Pharmaceuticals Reports Second Quarter 2022 Financial Results
5:30pm
10-Q
2022 Q2
AMLX
Amylyx Pharmaceuticals Inc
Quarterly report
11 Aug 22
4:16pm